Healthcare Professionals
Esophageal cancer is one of the deadliest cancers, and screening and surveillance often fail to detect the disease until it’s too late. We’ve created an advanced AI-assisted diagnostic platform that empowers physicians to dramatically increase the detection of Barrett’s esophagus and associated neoplasia before the disease can progress to cancer.
Testimonial
Watch Javier Sobrado, MD talk about screening test technology (1:51)
This proprietary diagnostic platform combines improved tissue sampling with the latest in artificial intelligence and 3D analysis to help physicians like you evaluate your patients with GERD and Barrett's esophagus, and to prevent esophageal cancer.
Advancing science throughout the aerodigestive tract. Learn More
Minimally invasive test for the oral cavity. Learn More
Minimally invasive test for the larynx and pharynx. Learn More
Case Study
Adjunctive use of AI-enabled diagnostic test helps overcome the sampling error inherent in the Seattle Protocol.
